Coronavirus disease 2019 (COVID-19) can have a potentially serious effect on your lungs. While some people can experience shortness of breath, others can develop pneumonia or a life-threatening ...

Millions of people sleep every night but never truly rest. Their breathing stops without them knowing it. This is Sleep apnea. On NDTV Lifeline podcast, we decode sleep apnea. Why it happens, how it ...

Philips Respironics, the maker of popular CPAP sleep apnea machines, has agreed to pay $479 million to settle some claims that its devices spewed carcinogenic foam and gas into the mouths of its ...

Add Yahoo as a preferred source to see more of our stories on Google. The Philips Center is seen on Jan. 27, 2015, in Amsterdam, Netherlands. Philips, the company behind a global recall of sleep apnea ...

In Rochester, N.Y., Diane Coleman has relied on a machine to help her stay alive, but she worries that it might be slowly undermining her health. Her ventilator was among millions of breathing devices ...

The U.S. Food and Drug Administration has updated a recall affecting millions of Philips sleep apnea machines, now saying that they may been linked to at least 561 deaths. The agency, in a statement ...

Certain Philips Respironics DreamStation breathing devices, commonly used for treating sleep apnea, may deliver the incorrect prescription or no therapy at all, the FDA warned in a recall announcement ...

(RTTNews) - Philips Respironics (PHGFF.PK, PHG) announced on Monday that on settling with the Food and Drug Administration, it has decided to halt the sales of the company's ventilators and CPAP ...

Philips Respironics has promised to replace millions of CPAP and BiPAP breathing machines that FDA reports have linked to thousands of injuries and more than 300 deaths.More than two years after the ...

For three years, Donald Camp has used a breathing device to sleep. He has severe sleep apnea, so without this device, his breathing is obstructed and he gasps for air. But in June, Camp and many ...

A new sleep apnea pill reduced symptoms by 44 per cent in trials, offering hope for patients struggling with uncomfortable ...